Akero Therapeutics, Inc.
US ˙ NasdaqGS ˙ US00973Y1082
이 기호는 더 이상 활성화되지 않습니다.

SecurityAKRO / Akero Therapeutics, Inc.
InstitutionGroup One Trading, L.p.
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Group One Trading, L.p. ownership in AKRO / Akero Therapeutics, Inc.

On February 11, 2026 - Group One Trading, L.p. filed a 13F-HR form disclosing ownership of 0 shares of Akero Therapeutics, Inc. (US:AKRO) valued at $0 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 12, 2025 disclosing 20,381 shares of Akero Therapeutics, Inc.. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Group One Trading, L.p. has a history of taking positions in derivatives of the underlying security (AKRO) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

AKRO / Akero Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-11 2025-12-31 13F AKERO THERAPEUTICS COM 00973Y108 0 -20,381 -100.00 0 -100.00
2025-11-12 2025-09-30 13F AKERO THERAPEUTICS COM 00973Y108 20,381 -5,336 -20.75 968 -29.52 0.0017
2025-08-14 2025-06-30 13F AKERO THERAPEUTICS COM 00973Y108 25,717 -4,063 -13.64 1,372 13.86 0.0030
2025-05-14 2025-03-31 13F AKERO THERAPEUTICS COM 00973Y108 29,780 29,780 1,205 0.0035
2024-08-14 2024-06-30 13F AKERO THERAPEUTICS COM 00973Y108 0 -2,416 -100.00 0 -100.00
2024-05-10 2024-03-31 13F AKERO THERAPEUTICS COM 00973Y108 2,416 -35,455 -93.62 61 -93.10 0.0002
2024-02-14 2023-12-31 13F AKERO THERAPEUTICS COM 00973Y108 37,871 12,853 51.38 884 -30.12 0.0023
2023-11-09 2023-09-30 13F AKERO THERAPEUTICS COM 00973Y108 25,018 -55,546 -68.95 1,265 -66.37 0.0043
2023-08-09 2023-06-30 13F AKERO THERAPEUTICS COM 00973Y108 80,564 80,417 54,705.44 3,762 75,120.00 0.0121
2023-05-12 2023-03-31 13F AKERO THERAPEUTICS COM 00973Y108 147 -124,481 -99.88 6 -99.93 0.0000
2023-02-09 2022-12-31 13F AKERO THERAPEUTICS COM 00973Y108 124,628 124,573 226,496.36 6,830 341,350.00 0.0159
2022-11-09 2022-09-30 13F AKERO THERAPEUTICS COM 00973Y108 55 -745 -93.12 2 -75.00 0.0000
2022-08-11 2022-06-30 13F AKERO THERAPEUTICS COM 00973Y108 800 -8,600 -91.49 8 -93.98 0.0000
2022-05-12 2022-03-31 13F AKERO THERAPEUTICS COM 00973Y108 9,400 9,400 133 0.0001
2021-08-10 2021-06-30 13F AKERO THERAPEUTICS COM 00973Y108 0 -43,885 -100.00 0 -100.00
2021-05-12 2021-03-31 13F AKERO THERAPEUTICS COM 00973Y108 43,885 43,819 66,392.42 1,273 63,550.00 0.0019
2021-02-10 2020-12-31 13F AKERO THERAPEUTICS COM 00973Y108 66 0 0.00 2 0.00 0.0000
2020-11-12 2020-09-30 13F AKERO THERAPEUTICS COM 00973Y108 66 -2,138 -97.01 2 -96.36 0.0000
2020-08-13 2020-06-30 13F AKERO THERAPEUTICS COM 00973Y108 2,204 -1,237 -35.95 55 -24.66 0.0003
2020-05-13 2020-03-31 13F AKERO THERAPEUTICS COM 00973Y108 3,441 3,441 73 0.0006
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-11 2025-12-31 13F AKERO THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-11-12 2025-09-30 13F AKERO THERAPEUTICS COM Call 27,400 -54.86 1,301 -59.85 n/a n/a n/a
2025-08-14 2025-06-30 13F AKERO THERAPEUTICS COM Call 60,700 879.03 3,239 1,195.20 n/a n/a n/a
2025-05-14 2025-03-31 13F AKERO THERAPEUTICS COM Call 6,200 -79.33 251 -70.02 n/a n/a n/a
2025-05-14 2024-12-31 13F/A AKERO THERAPEUTICS COM Call 30,000 22.95 835 19.14 n/a n/a n/a
2025-02-14 2024-12-31 13F AKERO THERAPEUTICS COM Call 30,000 835 n/a n/a n/a
2024-11-14 2024-09-30 13F AKERO THERAPEUTICS COM Call 24,400 10.41 700 35.14 n/a n/a n/a
2024-08-14 2024-06-30 13F AKERO THERAPEUTICS COM Call 22,100 -56.67 518 -59.78 n/a n/a n/a
2024-05-10 2024-03-31 13F AKERO THERAPEUTICS COM Call 51,000 -59.07 1,288 -55.72 n/a n/a n/a
2024-02-14 2023-12-31 13F AKERO THERAPEUTICS COM Call 124,600 2.89 2,909 -52.51 n/a n/a n/a
2023-11-09 2023-09-30 13F AKERO THERAPEUTICS COM Call 121,100 396.31 6,125 437.75 n/a n/a n/a
2023-08-09 2023-06-30 13F AKERO THERAPEUTICS COM Call 24,400 33.33 1,139 62.71 n/a n/a n/a
2023-05-12 2023-03-31 13F AKERO THERAPEUTICS COM Call 18,300 -42.81 700 -60.07 n/a n/a n/a
2023-02-09 2022-12-31 13F AKERO THERAPEUTICS COM Call 32,000 -29.05 1,754 14.13 n/a n/a n/a
2022-11-09 2022-09-30 13F AKERO THERAPEUTICS COM Call 45,100 1,536 n/a n/a n/a
2022-02-11 2021-12-31 13F AKERO THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-11-12 2021-09-30 13F AKERO THERAPEUTICS COM Call 500 150.00 11 120.00 n/a n/a n/a
2021-08-10 2021-06-30 13F AKERO THERAPEUTICS COM Call 200 -94.44 5 -95.19 n/a n/a n/a
2021-05-12 2021-03-31 13F AKERO THERAPEUTICS COM Call 3,600 3,500.00 104 3,366.67 n/a n/a n/a
2021-02-10 2020-12-31 13F AKERO THERAPEUTICS COM Call 100 3 n/a n/a n/a
2020-11-12 2020-09-30 13F AKERO THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-08-13 2020-06-30 13F AKERO THERAPEUTICS COM Call 8,200 204 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-11 2025-12-31 13F AKERO THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-11-12 2025-09-30 13F AKERO THERAPEUTICS COM Put 6,200 -67.54 294 -71.15 n/a n/a n/a
2025-08-14 2025-06-30 13F AKERO THERAPEUTICS COM Put 19,100 -51.89 1,019 -36.59 n/a n/a n/a
2025-05-14 2025-03-31 13F AKERO THERAPEUTICS COM Put 39,700 13,133.33 1,607 19,987.50 n/a n/a n/a
2025-05-14 2024-12-31 13F/A AKERO THERAPEUTICS COM Put 300 -96.51 8 -96.75 n/a n/a n/a
2025-02-14 2024-12-31 13F AKERO THERAPEUTICS COM Put 300 8 n/a n/a n/a
2024-11-14 2024-09-30 13F AKERO THERAPEUTICS COM Put 8,600 244.00 247 324.14 n/a n/a n/a
2024-08-14 2024-06-30 13F AKERO THERAPEUTICS COM Put 2,500 -88.48 59 -89.42 n/a n/a n/a
2024-05-10 2024-03-31 13F AKERO THERAPEUTICS COM Put 21,700 -86.63 548 -85.54 n/a n/a n/a
2024-02-14 2023-12-31 13F AKERO THERAPEUTICS COM Put 162,300 3.71 3,790 -52.13 n/a n/a n/a
2023-11-09 2023-09-30 13F AKERO THERAPEUTICS COM Put 156,500 -3.69 7,916 4.32 n/a n/a n/a
2023-08-09 2023-06-30 13F AKERO THERAPEUTICS COM Put 162,500 9,458.82 7,587 11,572.31 n/a n/a n/a
2023-05-12 2023-03-31 13F AKERO THERAPEUTICS COM Put 1,700 -99.26 65 -99.49 n/a n/a n/a
2023-02-09 2022-12-31 13F AKERO THERAPEUTICS COM Put 231,000 98.11 12,659 218.84 n/a n/a n/a
2022-11-09 2022-09-30 13F AKERO THERAPEUTICS COM Put 116,600 4,564.00 3,970 16,441.67 n/a n/a n/a
2022-08-11 2022-06-30 13F AKERO THERAPEUTICS COM Put 2,500 -73.40 24 -81.95 n/a n/a n/a
2022-05-12 2022-03-31 13F AKERO THERAPEUTICS COM Put 9,400 133 n/a n/a n/a
2021-11-12 2021-09-30 13F AKERO THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-08-10 2021-06-30 13F AKERO THERAPEUTICS COM Put 9,100 -92.52 226 -93.60 n/a n/a n/a
2021-05-12 2021-03-31 13F AKERO THERAPEUTICS COM Put 121,700 3,531 n/a n/a n/a
2020-11-12 2020-09-30 13F AKERO THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-08-13 2020-06-30 13F AKERO THERAPEUTICS COM Put 15,800 12.86 394 32.66 n/a n/a n/a
2020-05-13 2020-03-31 13F AKERO THERAPEUTICS COM Put 14,000 297 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.